BUND FINANCE

BUND FINANCE › Stocks › GSK

GSK plc (GSK)

NYSE · Stock price, chart and technical analysis

US$48.58-0.6600 (-1.34%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$49.24
OpenUS$49.03
Day rangeUS$48.55 – US$49.49
52-week rangeUS$45.81 – US$61.70
Market capUS$97.53B
Volume2.02M
50-day averageUS$49.32
200-day averageUS$52.38
Beta0.28
Last dividend per shareUS$1.83

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueGBP 24.7BGBP 29.3BGBP 30.3BGBP 31.4BGBP 32.7B
Net incomeGBP 4.4BGBP 15.0BGBP 4.9BGBP 2.6BGBP 5.7B
EPS (diluted)2.707.322.401.242.78
Gross margin67.0%67.4%71.8%71.2%72.4%
Operating margin17.6%21.9%22.2%12.8%24.3%
Net margin17.8%51.0%16.3%8.2%17.5%
Free cash flowGBP 5.3BGBP 6.8BGBP 4.4BGBP 3.6BGBP 4.8B
Total debtGBP 24.2BGBP 21.0BGBP 18.0BGBP 17.0BGBP 17.7B
CashGBP 4.3BGBP 3.7BGBP 2.9BGBP 3.7BGBP 3.4B

Compound annual growth: revenue 7.2% · net income 6.9% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E—12.4x27.1x
EV / EBITDA—9.4x16.5x
Operating margin20.4%—3.6%
Net margin13.0%—-0.0%
Debt / equity2.84—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation. The company reports in another currency: amounts are shown in that currency.

About GSK plc

SectorHealthcare
IndustryDrug Manufacturers - General
CountryGB
CEOLuke Victor Miels
Employees66,841
IPO date1980-03-28

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urog…

www.gsk.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice